Nothing Special   »   [go: up one dir, main page]

ES552796A0 - Un procedimiento para la preparacion de nuevos derivados de ciclopenta (d) pirimidina. - Google Patents

Un procedimiento para la preparacion de nuevos derivados de ciclopenta (d) pirimidina.

Info

Publication number
ES552796A0
ES552796A0 ES552796A ES552796A ES552796A0 ES 552796 A0 ES552796 A0 ES 552796A0 ES 552796 A ES552796 A ES 552796A ES 552796 A ES552796 A ES 552796A ES 552796 A0 ES552796 A0 ES 552796A0
Authority
ES
Spain
Prior art keywords
sup
procedure
preparation
hydrogen
cyclopenta
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES552796A
Other languages
English (en)
Other versions
ES8704905A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sankyo Co Ltd
Ube Corp
Original Assignee
Sankyo Co Ltd
Ube Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sankyo Co Ltd, Ube Industries Ltd filed Critical Sankyo Co Ltd
Publication of ES552796A0 publication Critical patent/ES552796A0/es
Publication of ES8704905A1 publication Critical patent/ES8704905A1/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
    • C07D239/72—Quinazolines; Hydrogenated quinazolines
    • C07D239/95—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in positions 2 and 4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Psychiatry (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Dental Preparations (AREA)
  • Hydrogenated Pyridines (AREA)
  • Saccharide Compounds (AREA)
  • Luminescent Compositions (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Eyeglasses (AREA)
  • Soil Working Implements (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
ES552796A 1985-03-07 1986-03-07 Un procedimiento para la preparacion de nuevos derivados de ciclopenta (d) pirimidina. Expired ES8704905A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP4362685 1985-03-07

Publications (2)

Publication Number Publication Date
ES552796A0 true ES552796A0 (es) 1987-04-16
ES8704905A1 ES8704905A1 (es) 1987-04-16

Family

ID=12669058

Family Applications (3)

Application Number Title Priority Date Filing Date
ES552796A Expired ES8704905A1 (es) 1985-03-07 1986-03-07 Un procedimiento para la preparacion de nuevos derivados de ciclopenta (d) pirimidina.
ES557199A Expired ES8801222A1 (es) 1985-03-07 1986-11-14 Un procedimiento para la preparacion de nuevos derivados de ciclopenta(d)pirimidina
ES557198A Expired ES8801221A1 (es) 1985-03-07 1986-11-14 Un procedimiento para la preparacion de nuevos derivados de ciclopenta(d)pirimidina

Family Applications After (2)

Application Number Title Priority Date Filing Date
ES557199A Expired ES8801222A1 (es) 1985-03-07 1986-11-14 Un procedimiento para la preparacion de nuevos derivados de ciclopenta(d)pirimidina
ES557198A Expired ES8801221A1 (es) 1985-03-07 1986-11-14 Un procedimiento para la preparacion de nuevos derivados de ciclopenta(d)pirimidina

Country Status (15)

Country Link
US (1) US4749704A (es)
EP (1) EP0194161B1 (es)
JP (1) JPS6270A (es)
KR (1) KR890003839B1 (es)
AT (1) ATE106077T1 (es)
AU (1) AU580391B2 (es)
CA (1) CA1273632A (es)
DE (1) DE3689848T2 (es)
DK (1) DK165109C (es)
ES (3) ES8704905A1 (es)
FI (1) FI88717C (es)
HK (1) HK1005450A1 (es)
IE (1) IE64504B1 (es)
NO (1) NO168767C (es)
ZA (1) ZA861708B (es)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5037980A (en) * 1988-04-18 1991-08-06 American Cyanamid Company Phenyl imidazo[1,2-a]pyrimidines
US5877178A (en) * 1991-04-08 1999-03-02 Duquesne University Of The Holy Ghost Pyrimidine derivatives and methods of making and using these derivatives
US5234936A (en) * 1991-10-24 1993-08-10 American Home Products Corporation Pyrimidocycloalkanes as a ii antagonists
ES2293317T3 (es) * 2003-08-12 2008-03-16 F. Hoffmann-La Roche Ag Derivados de tetrahidroquinazolina com antagonistas de cfr.
JPWO2007049342A1 (ja) 2005-10-26 2009-04-30 三菱電機株式会社 エレベーター群管理制御装置
RS52210B (en) 2006-07-06 2012-10-31 Array Biopharma, Inc. CYCLOPENT [D] PYRIMIDINS AS PROTEIN KINASE ACTION INHIBITORS
US9303040B2 (en) 2006-07-06 2016-04-05 Array Biopharma Inc. Substituted piperazines as AKT inhibitors
CA2656566C (en) 2006-07-06 2014-06-17 Array Biopharma Inc. Dihydrofuro pyrimidines as akt protein kinase inhibitors
US8063050B2 (en) 2006-07-06 2011-11-22 Array Biopharma Inc. Hydroxylated and methoxylated pyrimidyl cyclopentanes as AKT protein kinase inhibitors
WO2008021456A2 (en) * 2006-08-16 2008-02-21 Cytovia, Inc. N-aryl-5,7-dihydrofuro[3,4-d]pyrimidin-4-amines and analogs as activators of caspases and inducers of apoptosis and the use thereof
US9409886B2 (en) 2007-07-05 2016-08-09 Array Biopharma Inc. Pyrimidyl cyclopentanes as AKT protein kinase inhibitors
US8846683B2 (en) 2007-07-05 2014-09-30 Array Biopharma, Inc. Pyrimidyl cyclopentanes as Akt protein kinase inhibitors
AU2008272830B8 (en) 2007-07-05 2013-12-12 Array Biopharma Inc. Pyrimidyl cyclopentanes as AKT protein kinase inhibitors
CA2692506C (en) 2007-07-05 2015-11-24 Array Biopharma Inc. Pyrimidyl cyclopentanes as akt protein kinase inhibitors
BRPI0907372A2 (pt) 2008-01-09 2015-07-14 Array Biopharma Inc Pirimidil ciclopentano hidroxilado como inibidor de proteína quinase akt
CN101932564B (zh) 2008-01-09 2012-12-26 阵列生物制药公司 作为akt蛋白激酶抑制剂的羟基化嘧啶基环戊烷类
US8602172B2 (en) 2008-10-20 2013-12-10 Mitsubishi Electric Corporation Elevator group management system
AU2012236166A1 (en) 2011-04-01 2013-11-14 Genentech, Inc. Combinations of AKT inhibitor compounds and chemotherapeutic agents, and methods of use
EP2694073B1 (en) 2011-04-01 2018-08-08 Genentech, Inc. Combinations of akt and mek inhibitors for treating cancer
GB201121127D0 (en) 2011-12-08 2012-01-18 Dow Corning Treatment of filler with silane
CN111303053B (zh) * 2020-03-16 2023-01-17 中国海洋大学 环戊并[d]嘧啶类化合物及其药学上可接受的盐、溶剂合物或者前药以及应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3470182A (en) * 1967-02-09 1969-09-30 Sandoz Ag 4-amino-substituted quinazolines
US3980650A (en) * 1972-05-05 1976-09-14 N.V. Koninklijke Pharmaceutische Fabrieken V/H Brocades-Stheeman En Pharmacia 4-Amino-pyrimidine derivatives
US3915976A (en) * 1972-09-01 1975-10-28 Sandoz Ag Substituted-4-phenyl-5h-cycloalkano(d)pyrimidines
PH20344A (en) * 1981-01-29 1986-12-04 Sankyo Co Aminopyrimidine derivatives, processes for their preparation, and fungicidal, insecticidal and acaricidal compositions containing them
JPS57203072A (en) * 1981-06-05 1982-12-13 Sankyo Co Ltd 4-anilinopyrimidine derivative, its preparation, antidepressant comprising it as active ingredient

Also Published As

Publication number Publication date
ES557198A0 (es) 1988-01-01
DK106586A (da) 1986-09-08
EP0194161B1 (en) 1994-05-25
AU580391B2 (en) 1989-01-12
KR860007221A (ko) 1986-10-08
IE64504B1 (en) 1995-08-09
ES557199A0 (es) 1988-01-01
NO168767B (no) 1991-12-23
JPS6270A (ja) 1987-01-06
FI88717C (fi) 1993-06-28
NO168767C (no) 1992-04-01
DE3689848D1 (de) 1994-06-30
FI88717B (fi) 1993-03-15
KR890003839B1 (ko) 1989-10-05
IE860597L (en) 1986-09-07
CA1273632A (en) 1990-09-04
ES8801221A1 (es) 1988-01-01
DE3689848T2 (de) 1995-01-12
ATE106077T1 (de) 1994-06-15
ZA861708B (en) 1986-11-26
EP0194161A3 (en) 1987-09-02
FI860969A0 (fi) 1986-03-07
NO860852L (no) 1986-09-08
ES8801222A1 (es) 1988-01-01
DK165109B (da) 1992-10-12
FI860969A (fi) 1986-09-08
DK165109C (da) 1993-03-01
ES8704905A1 (es) 1987-04-16
EP0194161A2 (en) 1986-09-10
HK1005450A1 (en) 1999-01-08
US4749704A (en) 1988-06-07
DK106586D0 (da) 1986-03-07
AU5448186A (en) 1986-09-11

Similar Documents

Publication Publication Date Title
ES552796A0 (es) Un procedimiento para la preparacion de nuevos derivados de ciclopenta (d) pirimidina.
GR3023938T3 (en) 3',5'-ditertbutyl-4'-hydroxyflavones, method for their preparation and pharmaceutical compositions with an antioxidant and antivasoconstricting activity
ZA858418B (en) 5-alkyl-1-phenyl-2-piperazinoalkylpyrazoline-3-one compounds and methods for the preparation thereof,intermediates for use in the preparation of said compounds and medicaments containing said compounds
LV10422A (lv) Jaunie fluor-naftacendioni to glikozetie atvasinajumi un vinu razosanas panemiens
ES553207A0 (es) Un procedimiento para la preparacion de una octahidroindolizina
ATE77950T1 (de) Octahydroindolizine analgesica und 7-ketozwischenprodukte.
KR910006310A (ko) 신규한 나프탈렌 및 테트라히드로 나프탈렌 치환된 겜-디포스포네이트 유도체
JO1676B1 (en) Extra compounds indinol II
DE3561512D1 (de) Diphenylmethylimine derivatives
ES550781A0 (es) Un procedimiento para preparar un derivado de 1-benzhidril--4-cinamilpiperazina
ATE81465T1 (de) Verwendung von 2-oxo-imidazolidin-derivaten zur behandlung von nierenkrankheiten.

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 20010226